Regulator's Data Portal — Proof of Concept
← Back to Orphan Designations

Detailed SMPC and OD register data for: Reblozyl

Data as extracted from Orphan Designation Register

Product (OD)
Reblozyl
PL number (OD)
PLGB 15105/0153
OD Designation ID (OD)
OD2
Active substance (OD)
luspatercept Recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain

Data as extracted from SMPC. (PS: More information at bottom of the page)

Product (SMPC)
PL Number (SMPC)
Composition/ Active Substance (SMPC)
Dose form (SMPC)
Marketing Authorisation holder details (SMPC)

IDMP View

Structured regulatory data for this product mapped to the IDMP entity hierarchy (ISO 11615) — Marketing Authorisation, Medicinal Product, and Administrable Product.
Note: Wherever a type is listed as "Equivalent Term not known", we dont have the information available in public domain. However, this data is usually available in eAF (or equivalent) form and is stored by most regulators as strucutured data - albeit not always in same hierarchy as IDMP.

No IDMP data is linked to this authorisation number.

AI match to EMA Substance Dictionary

We analysed the SMPC composition text and searched for the closest equivalent in EMA's published substance dictionary. The suggested match and supporting details are shown below.

SMPC composition / active substance
Matched EMA substance
EMA SMS ID
Confidence
Higher confidence means the match is more likely to be correct.
Show AI rationale

FDA Approved Products —

Products approved by the FDA containing the matched EMA substance, sourced from OpenFDA Drugs@FDA.

No EMA substance match available — FDA lookup skipped.

Further information for:

Select a section below to read the detailed content extracted from the SMPC / Orphan Designation register.

OD Indication (OD)
In adults for the treatment of transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (MDS).
Full Designation Number(OD)
PLGB 15105/0153 - 0154/OD2
Orphan Condition(OD)
Myelodysplastic syndromes
All Indications (SMPC)
All Contraindications (SMPC)
Warnings/Precautions (SMPC)
Interactions (SMPC)
Pregnancy/Lactation (SMPC)
Driving/Machines (SMPC)
Undesirable effects (SMPC)
Overdose (SMPC)
Shelf life (SMPC)
Storage (SMPC)
Container description (SMPC)
Handling/Disposal (SMPC)
SMPC_URL

Link to SMPC: Not available